On October 7, 2021, five years after issuing initial draft guidance on its enforcement approach for hospitals and health system pharmacy compounding under section 503A of the Food, Drug, and Cosmetic Act (the “Act”), the U.S. Food and Drug Administration (“FDA”) released revised draft guidance (“Draft Guidance”) that provides increased flexibility to hospitals and health... READ MORE
FDA Revises Health System Compounding Guidance, Implementing a More Practical Approach
Posted on October 14, 2021 in Health Law News
Published by: Hall Render
